Clinical trial
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in…
NCT00060398 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00060398 |
|---|---|
| Title | Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer |
| Official title | Study Of Epoetin Alfa Vs Epoetin Alfa With Dexamethasone In Hormone Refractory Prostate Cancer Patients: Impact On Fatigue, Anemia, Functional Status And Quality Of Life |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Fatigue, Prostate Cancer |
| Intervention type | Biological, Drug |
| Interventions | epoetin alfa, dexamethasone |
| Enrollment | 282 |
| Start date | Sep 29, 2004 |
| Primary completion | Jun 1, 2006 |
| First posted | May 7, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: